Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06848595
PHASE3

Mg Sulfate Versus Dexmedetomidine on Cerebral Oxygen Saturation

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

This study is to evaluate the effects of dexmedetomidine and magnesium sulfate on cerebral oxygen saturation in patients undergoing spine surgeries as adjuvant to general anesthesia guided by cerebral oximetry. The main aims to are Incidence of cerebral desaturation events and duration of cerebral desaturation events.

Official title: Effects of Dexmedetomidine Versus Magnesium Sulfate on Cerebral Oxygen Saturation During Spine Surgery: a Prospective Randomized Controlled Study

Key Details

Gender

All

Age Range

21 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2025-02-23

Completion Date

2027-01-31

Last Updated

2025-02-27

Healthy Volunteers

No

Interventions

PROCEDURE

spine surgery

spine surgery in prone position

DRUG

Magnesium sulfate

Patients will receive loading dose of 40 mg/kg of magnesium sulfate diluted in 50 ml of 0.9% saline IVI will be given in 10 min before anesthesia induction then continuous infusion of 10 mg/kg/hour during the surgery.

DRUG

Dexmedetomidine

Patients will receive loading dose of 1 mcg/kg dexmedetomidine diluted in 50 ml of saline 0.9% IVI will be given in 10 min before anesthesia induction then continuous infusion of 0.5 mcg/kg/hour during the surgery.

DRUG

Normal Saline (0.9% NaCl)

Patients will receive the same volume of normal saline.